Form 4: Cingulate Inc. Director Peter J. Werth Converts Debt to Pre-Funded Warrants

Peter J. Werth, a director and 10% owner of Cingulate Inc., converted debt held by Werth Family Investment Associates LLC into pre-funded warrants to purchase shares of common stock.

Summary

• On March 25, 2024, Peter J. Werth, a director and 10% owner of Cingulate Inc., reported the conversion of debt into pre-funded warrants.
• Werth Family Investment Associates LLC (WFIA) converted $3,287,500 of debt plus accrued interest into warrants to purchase 687,043 shares of common stock at $4.785 per warrant.
• An additional $33,750 in outstanding interest was converted into warrants to purchase 7,053 shares at the same price.
• The pre-funded warrants are immediately exercisable but are limited to ensure that Werth and his affiliates do not exceed 19.99% ownership of Cingulate's outstanding common stock.
• Werth disclaims beneficial ownership of the securities held by WFIA except to the extent of his pecuniary interest.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The debt conversion is a standard financial transaction. The impact depends on the company's overall financial health and the market's perception of the conversion price.

Positives

• The conversion of debt to equity can be seen as a positive sign, reducing the company's debt burden.
• The immediate exercisability of the warrants could provide Cingulate with additional capital if exercised.

Negatives

• The conversion price of $4.785 may be viewed relative to the current market price of Cingulate Inc. shares.
• The potential dilution of existing shareholders if the warrants are exercised.

Risks

• The exercise of the warrants could dilute existing shareholders.
• The 19.99% ownership limit suggests a potential concern about triggering certain ownership thresholds.

Future Outlook

The document does not contain specific forward-looking statements beyond the immediate transaction.

Industry Context

Debt conversions are a common financial maneuver, especially for smaller companies seeking to strengthen their balance sheets. The specifics of the conversion price and ownership limits are tailored to the company's situation and regulatory requirements.

Comparison to Industry Standards

• Debt-to-equity conversions are frequently used by companies in the pharmaceutical and biotech industries, especially during the development phase, to manage their capital structure.
• Similar transactions can be seen with companies like BioCryst Pharmaceuticals and Amarin Corporation, where debt was converted to equity to improve financial flexibility.
• The conversion price is a key factor, and its attractiveness depends on the company's current valuation and future growth prospects.

Related Party Transactions

• The transaction involves Werth Family Investment Associates LLC, a related party due to Peter J. Werth's affiliation.

Stakeholder Impact

• Shareholders may experience dilution if the warrants are exercised.
• The company's financial stability could be improved by reducing debt.

Key Dates

Keywords

pre-funded warrants, Cingulate Inc., Werth Family Investment Associates LLC, debt conversion, beneficial ownership, Form 4, CING